Fanucchi MP - Search Results

1

Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer.

Kris MG, Kinahan JJ, Gralla RJ, Fanucchi MP, Wertheim MS, O'Connell JP, Marks LD, Williams L, Farag F, Young CW, et al. Kris MG, et al. Among authors: fanucchi mp. Cancer Res. 1988 Oct 1;48(19):5573-9. Cancer Res. 1988. PMID: 3416310 Clinical Trial.

2

Toxicity, elimination, and metabolism of 10-ethyl-10-deazaaminopterin in rats and dogs.

Fanucchi MP, Kinahan JJ, Samuels LL, Hancock C, Chou TC, Niedzwiecki D, Farag F, Vidal PM, DeGraw JI, Sternberg SS, et al. Fanucchi MP, et al. Cancer Res. 1987 May 1;47(9):2334-9. Cancer Res. 1987. PMID: 2436760

3

Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals.

Young CW, Fanucchi MP, Declan Walsh T, Baltzer L, Yaldaei S, Stevens YW, Gordon C, Tong W, Rifkind RA, Marks PA. Young CW, et al. Among authors: fanucchi mp. Cancer Res. 1988 Dec 15;48(24 Pt 1):7304-9. Cancer Res. 1988. PMID: 3191501

4

Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.

Kris MG, D'Acquisto RW, Gralla RJ, Burke MT, Marks LD, Fanucchi MP, Heelan RT. Kris MG, et al. Among authors: fanucchi mp. Am J Clin Oncol. 1989 Feb;12(1):24-6. doi: 10.1097/00000421-198902000-00006. Am J Clin Oncol. 1989. PMID: 2536213

5

Fluorometric high-performance liquid chromatographic analysis of 10-deazaaminopterin, 10-ethyl-10-deazaaminopterin, and known metabolites.

Kinahan JJ, Samuels LL, Farag F, Fanucchi MP, Vidal PM, Sirotnak FM, Young CW. Kinahan JJ, et al. Among authors: fanucchi mp. Anal Biochem. 1985 Oct;150(1):203-13. doi: 10.1016/0003-2697(85)90460-9. Anal Biochem. 1985. PMID: 2417507

6

Phase I and clinical pharmacology study of trimetrexate administered weekly for three weeks.

Fanucchi MP, Walsh TD, Fleisher M, Lokos G, Williams L, Cassidy C, Vidal P, Chou TC, Niedzwiecki D, Young CW. Fanucchi MP, et al. Cancer Res. 1987 Jun 15;47(12):3303-8. Cancer Res. 1987. PMID: 2953412

7

Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU).

Fanucchi MP, Leyland-Jones B, Young CW, Burchenal JH, Watanabe KA, Fox JJ. Fanucchi MP, et al. Cancer Treat Rep. 1985 Jan;69(1):55-9. Cancer Treat Rep. 1985. PMID: 2981621

8

Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections.

Feinberg A, Leyland-Jones B, Fanucchi MP, Hancock C, Fox JJ, Watanabe KA, Vidal PM, Williams L, Young CW, Philips FS. Feinberg A, et al. Among authors: fanucchi mp. Antimicrob Agents Chemother. 1985 May;27(5):733-8. doi: 10.1128/AAC.27.5.733. Antimicrob Agents Chemother. 1985. PMID: 2990323 Free PMC article.

9

Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies.

Kauh J, Chanel-Vos C, Escuin D, Fanucchi MP, Harvey RD, Saba N, Shin DM, Gal A, Pan L, Kutner M, Ramalingam SS, Bender L, Marcus A, Giannakakou P, Khuri FR. Kauh J, et al. Among authors: fanucchi mp. Cancer. 2011 Sep 1;117(17):4049-59. doi: 10.1002/cncr.26004. Epub 2011 Mar 1. Cancer. 2011. PMID: 21365629 Free PMC article. Clinical Trial.

10

Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA).

Arlin ZA, Fanucchi MP, Gee TS, Kempin SJ, Mertelsmann R, Young CW, Clarkson BD. Arlin ZA, et al. Among authors: fanucchi mp. Blood. 1982 Nov;60(5):1224-6. Blood. 1982. PMID: 6957250 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters